Henderson Mary Elizabeth — SEC Form 4 filings
SEC reporting owner CIK 1989533. 11 Form 4 filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-03-05 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 8,991 shares, $1,571,203 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 5,343 shares @ $194.49 ($1,039,134) in Jazz Pharmaceuticals plc, filed 2026-03-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | SVP, Technical Operations | 11 | — | 3 legs · 8,991 sh · $1,571,203 | 12 |
Form 4 filings — Henderson Mary Elizabeth
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 1,412 @ $243.03 · Tax withholding (F): 15 @ $241.20 | EDGAR |
| 2026-09-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 2,076 @ $241.39 · Tax withholding (F): 16 @ $244.64 | EDGAR |
| 2026-03-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 1,394 @ $186.75 | EDGAR |
| 2026-03-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 4,447 @ $0 · Sale (S): 5,343 @ $194.49 | EDGAR |
| 2026-01-21 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 10,116 @ $0 | EDGAR |
| 2025-12-11 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 2,238 @ $169.51 | EDGAR |
| 2025-11-21 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Disposition to issuer (D): 1,331 @ $180.40 | EDGAR |
| 2025-03-11 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Disposition to issuer (D): 698 @ $138.23 | EDGAR |
| 2025-03-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 5,392 @ $0 · Grant/award (A): 3,852 @ $0 | EDGAR |
| 2024-09-11 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,410 @ $108.30 | EDGAR |
| 2024-03-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 5,178 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1989533 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →